Evidence map›Paper›PMID 39636959›Full record

ArticlePloS one2024

Quantum game strategy solution for R&D cartel: Reorganizing government R&D investment strategy in Korea.

Dongkyu Won, Jongyeon Lim, BangRae Lee

Abstract read
In one paragraph

Article in PloS one, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Dongkyu WonCenter for R&D Investment and Strategy Research, Korea Institute of Science and Technology Information, Seoul, Republic of Korea.ORCID 0000-0001-8503-6122
Jongyeon LimCenter for R&D Investment and Strategy Research, Korea Institute of Science and Technology Information, Seoul, Republic of Korea.ORCID 0000-0003-4084-5908
BangRae LeeCenter for R&D Investment and Strategy Research, Korea Institute of Science and Technology Information, Seoul, Republic of Korea.ORCID 0000-0003-2472-1761

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This study reevaluates criticism of the Korean government's R&D investment strategy, which was considered an 'R&D cartel' and was cited as a reason for the Korean government's R&D cuts in 2023, through an advanced framework of quantum game theory. By modeling the interaction between the government and researchers as a quantum information strategy game, it redefines the dynamics of R&D investment as a quantum game involving two key players: the R&D manager (Alice) and the research performer (Bob). This quantum game, akin to the Prisoner's Dilemma but focused on responsibility and sincerity, allows for the exploration of strategic complexities and decision-making dynamics not possible in classical models. It introduces quantum entanglement and superposition as innovative strategies to shift the paradigm of R&D investment, suggesting that terms like 'R&D bureaucracy' and 'R&D monopoly' more accurately describe the moral hazards in this sector than 'R&D cartel'. Through simulations, the paper demonstrates how quantum strategies can significantly alter outcomes, providing fresh insights and policy alternatives for R&D innovation. This research not only challenges conventional investment frameworks but also proposes a novel approach for achieving Pareto optimal outcomes in government R&D investments, emphasizing the transformative potential of quantum game theory in strategic decision-making and policy development.

Indexed as

Game TheoryInvestmentsDecision MakingGovernmentHumansQuantum TheoryRepublic of KoreaResearch

Identifiers

PMID39636959
PMCPMC11620664

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.